|
1
|
Dolecek TA, Propp JM, Stroup NE and
Kruchko C: CBTRUS statistical report: Primary brain and central
nervous system tumors diagnosed in the United States in 2005–2009.
Neuro Oncol. 14 Suppl 5:v1–v49. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xiong Y, Liu L, Zhu S, Zhang B, Qin Y, Yao
R, Zhou H and Gao DS: Precursor N-cadherin mediates glial cell
line-derived neurotrophic factor-promoted human malignant glioma.
Oncotarget. 8:24902–24914. 2017.PubMed/NCBI
|
|
3
|
Kourtidis A, Lu R, Pence LJ and
Anastasiadis PZ: A central role for cadherin signaling in cancer.
Exp Cell Res. 358:78–85. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Halbleib JM and Nelson WJ: Cadherins in
development: Cell adhesion, sorting, and tissue morphogenesis.
Genes Dev. 20:3199–3214. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goodwin M and Yap AS: Classical cadherin
adhesion molecules: Coordinating cell adhesion, signaling and the
cytoskeleton. J Mol Histol. 35:839–844. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rosivatz E, Becker I, Bamba M, Schott C,
Diebold J, Mayr D, Höfler H and Becker KF: Neoexpression of
N-cadherin in E-cadherin positive colon cancers. Int J Cancer.
111:711–719. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han AC, Soler AP, Knudsen KA and Salazar
H: Distinct cadherin profiles in special variant carcinomas and
other tumors of the breast. Hum Pathol. 30:1035–1039. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tomita K, van Bokhoven A, van Leenders GJ,
Ruijter ET, Jansen CF, Bussemakers MJ and Schalken JA: Cadherin
switching in human prostate cancer progression. Cancer Res.
60:3650–3654. 2000.PubMed/NCBI
|
|
9
|
Giroldi LA, Bringuier PP, Shimazui T,
Jansen K and Schalken JA: Changes in cadherin-catenin complexes in
the progression of human bladder carcinoma. Int J Cancer. 82:70–76.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Asano K, Duntsch CD, Zhou Q, Weimar JD,
Bordelon D, Robertson JH and Pourmotabbed T: Correlation of
N-cadherin expression in high grade gliomas with tissue invasion. J
Neurooncol. 70:3–15. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maret D, Gruzglin E, Sadr MS, Siu V, Shan
W, Koch AW, Seidah NG, Del Maestro RF and Colman DR: Surface
expression of precursor N-cadherin promotes tumor cell invasion.
Neoplasia. 12:1066–1080. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin LF, Doherty DH, Lile JD, Bektesh S and
Collins F: GDNF: A glial cell line-derived neurotrophic factor for
midbrain dopaminergic neurons. Science. 260:1130–1132. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sariola H and Saarma M: Novel functions
and signalling pathways for GDNF. J Cell Sci. 116:3855–3862. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Airaksinen MS and Saarma M: The GDNF
family: Signalling, biological functions and therapeutic value. Nat
Rev Neurosci. 3:383–394. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wiesenhofer B, Stockhammer G, Kostron H,
Maier H, Hinterhuber H and Humpel C: Glial cell line-derived
neurotrophic factor (GDNF) and its receptor (GFR-alpha 1) are
strongly expressed in human gliomas. Acta Neuropathol. 99:131–137.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sainio K, Suvanto P, Davies J, Wartiovaara
J, Wartiovaara K, Saarma M, Arumäe U, Meng X, Lindahl M, Pachnis V,
et al: Glial-cell-line-derived neurotrophic factor is required for
bud initiation from ureteric epithelium. Development.
124:4077–4087. 1997.PubMed/NCBI
|
|
17
|
Meng X, Lindahl M, Hyvönen ME, Parvinen M,
de Rooij DG, Hess MW, Raatikainen-Ahokas A, Sainio K, Rauvala H,
Lakso M, et al: Regulation of cell fate decision of
undifferentiated spermatogonia by GDNF. Science. 287:1489–1493.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang BL, Guo TW, Gao LL, Ji GQ, Gu XH,
Shao YQ, Yao RQ and Gao DS: Egr-1 and RNA POL II facilitate glioma
cell GDNF transcription induced by histone hyperacetylation in
promoter II. Oncotarget. 8:45105–45116. 2017.PubMed/NCBI
|
|
19
|
Sun S, Lei Y, Li Q, Wu Y, Zhang L, Mu PP,
Ji GQ, Tang CX, Wang YQ, Gao J, et al: Neuropilin-1 is a glial cell
line-derived neurotrophic factor receptor in glioblastoma.
Oncotarget. 8:74019–74035. 2017.PubMed/NCBI
|
|
20
|
Paratcha G, Ledda F and Ibáñez CF: The
neural cell adhesion molecule NCAM is an alternative signaling
receptor for GDNF family ligands. Cell. 113:867–879. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cao JP, Wang HJ, Yu JK, Yang H, Xiao CH
and Gao DS: Involvement of NCAM in the effects of GDNF on the
neurite outgrowth in the dopamine neurons. Neurosci Res.
61:390–397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cao JP, Yu JK, Li C, Sun Y, Yuan HH, Wang
HJ and Gao DS: Integrin beta1 is involved in the signaling of glial
cell line-derived neurotrophic factor. J Comp Neurol. 509:203–210.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zuo T, Qin JY, Chen J, Shi Z, Liu M, Gao X
and Gao D: Involvement of N-cadherin in the protective effect of
glial cell line-derived neurotrophic factor on dopaminergic neuron
damage. Int J Mol Med. 31:561–568. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jaye M, Schlessinger J and Dionne CA:
Fibroblast growth factor receptor tyrosine kinases: Molecular
analysis and signal transduction. Biochim Biophys Acta.
1135:185–199. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Turner N and Grose R: Fibroblast growth
factor signalling: From development to cancer. Nat Rev Cancer.
10:116–129. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang S and Ding Z: Fibroblast growth
factor receptors in breast cancer. Tumour Biol.
39:10104283176983702017.PubMed/NCBI
|
|
27
|
Carter EP, Fearon AE and Grose RP:
Careless talk costs lives: Fibroblast growth factor receptor
signalling and the consequences of pathway malfunction. Trends Cell
Biol. 25:221–233. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ornitz DM and Itoh N: The fibroblast
growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol.
4:215–266. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kelleher FC, O'Sullivan H, Smyth E,
McDermott R and Viterbo A: Fibroblast growth factor receptors,
developmental corruption and malignant disease. Carcinogenesis.
34:2198–2205. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xian W, Schwertfeger KL, Vargo-Gogola T
and Rosen JM: Pleiotropic effects of FGFR1 on cell proliferation,
survival, and migration in a 3D mammary epithelial cell model. J
Cell Biol. 171:663–673. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dienstmann R, Rodon J, Prat A,
Perez-Garcia J, Adamo B, Felip E, Cortes J, Iafrate AJ, Nuciforo P
and Tabernero J: Genomic aberrations in the FGFR pathway:
Opportunities for targeted therapies in solid tumors. Ann Oncol.
25:552–563. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bae JH, Lew ED, Yuzawa S, Tomé F, Lax I
and Schlessinger J: The selectivity of receptor tyrosine kinase
signaling is controlled by a secondary SH2 domain binding site.
Cell. 138:514–524. 2009. View Article : Google Scholar : PubMed/NCBI
|
